Stay updated on Olaparib in gBRCA Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page.

Latest updates to the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page
- Check7 days agoChange DetectedThe page now shows revision v3.5.5, replacing v3.5.4, indicating a new site update. This metadata change does not alter study data, eligibility criteria, or any content on the page.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedRevision label on the page has been updated from v3.5.3 to v3.5.4. This reflects a new page revision without changes to the study content or layout.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page’s “Revision” identifier was updated from v3.5.2 to v3.5.3. This reflects a platform/version update without changing the study record content shown.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This is a system-level version update and does not alter study content.SummaryDifference0.0%

- Check72 days agoChange DetectedPadua, Italy 35128 was removed from the locations and Padova, Italy 35128 was added to the locations.SummaryDifference0.0%

- Check86 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a frontend build/version change with no visible alterations to study details, eligibility criteria, or results on the page.SummaryDifference0.0%

Stay in the know with updates to Olaparib in gBRCA Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page.